Skip to content

Twelve-month follow-up of Dental Restorations in people undergoing treatment for Head and Neck Cancer: a clinical study comparing two materials

12-month evaluation of Restorations with “Bioactive” Material in patients that underwent Head and Neck Cancer treatment: double-blind, controlled and randomized clinical trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-77968p8
Enrollment
Unknown
Registered
2026-01-09
Start date
2025-05-09
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental caries, unspecified.

Interventions

This is a double-blind, controlled, randomized, split-mouth clinical study. A total of 49 people who meet the eligibility criteria will be probabilistically allocated to one or the other intervention
bioactive&quot
group, which characterizes the study as split-mouth. Neither the researchers who will evaluate the outcomes nor the participants will know which group each participant belongs to. Experimental group:
material Beautifil II from Shofu Inc. Control group: the same 49 people will also receive a direct dental restoration with the control material NeoSpectra from Dentsply Sirona. The restorations will b

Sponsors

Faculdade de Odontologia de Piracicaba - Universidade Estadual de Campinas
Lead Sponsor
Instituto do Câncer do Estado de São Paulo - ICESP
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have undergone treatment for head and neck cancer (radiotherapy); both genders; over 18 years of age; have at least two carious cervical lesions; oral health consistent with the Simplified Oral Hygiene Index.

Exclusion criteria

Exclusion criteria: Patients with orthodontic appliances; those allergic to resin-based materials; those who have not undergone radiotherapy for head and neck cancer treatment.

Design outcomes

Primary

MeasureTime frame
To evaluate the ability of a bioactive composite containing S-PRG (Surface Pre Reacted Glass) fillers to prevent or control the development of recurrent caries around restorations. Assessment will be performed through clinical examination using the "World Dental Federation" (FDI) criteria and/or the modified United States Public Health Service (USPHS) criteria. Recurrent caries will be considered present when scores indicate changes in marginal adaptation, marginal staining, or restoration integrity consistent with clinical failure according to the cut-off points established in these criteria.

Secondary

MeasureTime frame
It is expected that the restorative composite containing S-PRG fillers will be able to prevent or control the development of recurrent caries around restorations, assessed through complementary clinical evaluation using the FDI criteria and/or the modified USPHS criteria. A favorable response will be defined as the maintenance or improvement of clinical scores related to marginal staining, marginal integrity, and structural integrity of the restorative material, as well as the absence of lesion progression throughout the follow-up period.

Countries

Brazil

Contacts

Public ContactLuana Soares

Faculdade de Odontologia de Piracicaba - Universidade Estadual de Campinas

luanamsoares209@gmail.com+55 (19) 2106-5341

Outcome results

None listed

Source: REBEC (via WHO ICTRP)